Company Search:
Advanced Search
Sponsored Links
Read-Gene SA Company Snapshot
Read-Gene SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Read-Gene SA with three other miscellaneous service companies in Europe: Oxford Biodynamics PLC of the United Kingdom (2016 sales of £1.09 million [US$1.49 million] of which 100% was Pharmaceutical), Wilex Ag of Germany (1.36 million Euro [US$1.65 million] ), and Plant Advanced Technologies PAT SA which is based in France (1.15 million Euro [US$1.40 million] ).

Sales Analysis. Read-Gene SA reported sales of 5.23 million Polish New Zlotys (US$1.52 million) for the year ending December of 2016. This represents an increase of 139.1% versus 2015, when the company's sales were 2.19 million Polish New Zlotys. This was the third consecutive year of growth at Read-Gene SA.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Read-Gene SA
  Stock Performance Chart for Read-Gene SA
  Stock Data: Recent Stock Performance:
  Current Price (12/29/2017): 1.56
(Figures in Polish New Zlotys)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Read-Gene SA Key Data:
  Ticker: RDG Country: Poland
  Exchanges: WAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 5,226,100
(Year Ending Jan 2017).
Employees: 6
  Currency: Polish New Zlotys Market Cap: 18,548,416
  Fiscal Yr Ends: December Shares Outstanding: 11,890,010
  Share Type: Akcje Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.